http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_872ff61f8f74f9d297965fb512a37b15
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Lupu |
| name | Florea Lupu |
| given-name | Florea |
| organization-name | *The Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium; ‡Chiron Corporation, Emeryville, California; §The Haemobiology Research Department, Sanofi Recherche, Toulouse, France; and ‖The Vascular Biology Laboratory, The Thrombosis Research Institute, London, UK From Imperial College School of Medicine, National Heart and Lung Institute (H-I.Y., E.D., N.J.S.), and the Thrombosis Research Institute (F.L.), London, UK. From the Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium (H.R.L., B.V.H., D.C.); the Vascular Biology Laboratory, Thrombosis Research Institute, London, UK (F.L.); and the Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium (L.M., P.C., D.C.). From the Thrombosis Research Institute, Chelsea, London. Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma From the Institute for Biochemistry and the Department of Internal Medicine, Justus-Liebig-University, Giessen, Germany; Weston Center for Experimental Research, Thrombosis Research Institute, Manresa Road, London, England; Institute for Physiological Chemistry, Johannes-Gutenberg-Universität, Mainz, Germany; and the Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA. From the Vascular Biology Laboratory, Thrombosis Research Institute, London, and the Department of Cardiac Medicine (N.J.S.), NHLI, Imperial College, London, UK. Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation 1 , 2 , and 3; Department of Biochemistry and Molecular Biology 1 , 2 , and 3; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104 1 , 2 , and 3; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation 1 , 2 , and 3; Department of Biochemistry and Molecular Biology 1 , 2 , and 3; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104 1 , 2 , and 3 Cardiovascular Biology Program Oklahoma Medical Research Foundation Oklahoma City OK USA Cardiovascular Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK USA From the Thrombosis Research Institute (F.L., F.B., V.V.K.), London, UK, and the Division of Hematology, Department of Medicine (F.L., D.A.H., F.B., E.K.O.K.) and Cardiovascular Surgery Service (M.H.), University Hospital Center (CHUV), Lausanne, Switzerland. From the Vascular Biology Laboratory, Weston Centre for Experimental Research, Thrombosis Research Institute, London, and the Department of Histopathology (T.K.), Imperial College School of Medicine, Hammersmith Hospital, London, UK. Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK (Y.-C.H., X.G., R.V., K.S., Z.J.A.-N., J.K., R.S., L.C., B.C., L.X., F.L., L.E.O., J.A., R.S.S.). Cardiovascular Biology Research Program,Oklahoma Medical Research Foundation; Department of Cell Biology,University of Oklahoma Health Sciences Center,Oklahoma City,OK From the Gaubius Laboratory TNO-PG, Leiden, The Netherlands; Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City; Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands. From the Center for Transgene Technology and Gene Therapy (P.C., L.M., D.C., R.D.G.), Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; Laboratory of Experimental Cardiology (S.J.), University of Leuven, Leuven, Belgium; Vascular Biology Laboratory (F.L.), Thrombosis Research Institute, London, UK; and Department of Biochemistry and Internal Medicine (R.D.G.), University of Texas Southwestern Medical Center, Dallas, Tex. Programs in Cardiovascular Biology Oklahoma Medical Research Foundation Oklahoma City OK USA; Department of Pathology Oklahoma University Health Sciences Center Oklahoma City OK USA; Department of Cell Biology Oklahoma University Health Sciences Center Oklahoma City OK USA From the Platelet Section, Thrombosis Research Institute, London, UK, and the Department of Pharmacology, State University of New York Health Science Center, Syracuse, NY. Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and; Departments of Pathology and From the Center for Transgene Technology and Gene Therapy (A.L., E.S., M.F.H., L.M., D.C., P.C.), Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium; Cardiovascular Biology Research Program (F.L., J.C.), Oklahoma Medical Research Foundation, Oklahoma City; the Cardiovascular/Thrombosis Research Department (F.B., J.-M.H.), Sanofi-Synthélabo, Toulouse, France; Joint Diseases Laboratory (A.R.P.), Shriners Hospitals for Children, McGill University, Montreal, Quebec, Canada; and the... From the Center for Transgene Technology and Gene Therapy (P.C., L.M., R.L., D.C.), Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium; the Haemobiology Research Department (J.-M.H., ), Sanofi Recherche, Toulouse, France; and the Vascular Biology Laboratory (J.C., F.L.), the Thrombosis Research Institute, London, UK. From the Thrombosis Research Institute (J.T.B.C., D.A.G., F.L.), London, England; the Oklahoma Medical Research Foundation (J.T.B.C., F.L.), Oklahoma City, Oklahoma; the Center for Molecular Microbiology (D.A.G.), Imperial College, London, England; the Academic Medical Center (V.F.), University of Amsterdam, Amsterdam, Netherlands; and the National Heart and Lung Institute (N.J.S.), Imperial College, London, England. The Vascular Biology Laboratory, Thrombosis Research Institute, Chelsea, London, UK *Cardiovascular Biology Research Program Department of Cardiovascular Biology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma. Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation (R.S.K., F.L.). Oklahoma Medical Research Foundation Oklahoma City From the Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City (M.T.M., E.-C.O., B.T.S, V.M., R.S.-M., F.L., C.T.G.); and Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City (F.L., C.T.G.). 2Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104 Cardiovascular Research Program, Oklahoma Medical Research Foundation, Oklahoma City Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK;; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK; and Cardiovascular Biology Research Program Oklahoma Medical Research Foundation Oklahoma City OK; Department of Cell Biology University of Oklahoma Health Sciences Center Oklahoma City OK; Department of Pathology University of Oklahoma Health Sciences Center Oklahoma City OK Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and Oklahoma Medical Research Foundation, Oklahoma City; From the Department of Biochemistry (A.A.-S., H.P.), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, and the Vascular Biology Laboratory (F.L.), Weston Centre for Experimental Research, Thrombosis Research Institute, London, UK. From the Vascular Biology Laboratory, Weston Centre for Experimental Research, Thrombosis Research Institute, London, United Kingdom. Cardiovascular Biology Research Program; Oklahoma Medical Research Foundation; Oklahoma City, OK USA 1Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, and; Department of Pathology, Oklahoma University Health Sciences Center, Oklahoma City Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Departments of Cell Biology and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma J.D.L. and F.L. cosupervised this study.; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City;; Departments of Pathology and Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; From the Vesalius Research Center, Flanders Institute for Biotechnology (VIB), Leuven, Belgium (G.W., D.N., J.S., A.V.N., L.M., P.C., D.C., M.D.); Vesalius Research Center (G.W., D.N., J.S., A.V.N., L.M., P.C., D.C., M.D.) and Laboratory of Biological Psychology (Z.C.-V., R.D.), University of Leuven, Leuven, Belgium; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK (R.S.-M., F.L.). Cardiovascular Biology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City (R.S.K., F.L.) From the Thrombosis Research Institute, London, UK (C.L., C.A.G., A.D.W., M.F.S., V.V.K., F.L.), and the Gaubius TNO Institute of Vascular Research, Leiden, The Netherlands (J.J.E.). Cardiovascular Biology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation (R.S., F.L.) From the Cardiovascular Biology Research Program (L.I., H.T., F.L., C.L.), Oklahoma Medical Research Foundation, Oklahoma City; the Department of Internal Medicine (R.D.G.), University of Texas Southwestern Medical Center, Dallas; and the Department of Pathology (F.L.), Oklahoma University Health Sciences Center, Oklahoma City. |
Incoming Links
Total number of triples: 180.